1G. Saggese,S. Bertelloni,G. I. Baroncelli,G. Nero. Serum levels of carboxyterminal propeptide of type I procollagen in healthy children from 1 st year of life to adulthood and in metabolic bone diseases[J] 1992,European Journal of Pediatrics(10):764～768
2Chen KM,Ge BF,Ma HP,el a1.Icariin,a flavonoid from the herb Epimedium enhances the osteogenic differentiation of rat primary bone marrow stromal cells[J].Pharmazie.2005,60(12):939-942.
3Wang ZQ,Lou YJ.Proliferation-stimulating effects of icaritin and desmethylicaritin in MCF-7 cells[J].Eur J Pharmacol,2004,504(3):147-153.
4Huang J,Yuan L,Wang X,et al.Icaritin and glycosides enchance osteoblastic,but suppress osteoclastic,differentiation and activity in vitro[J].Life Sci,2007,81(10):832-840.
6Harden CL. Therapeutic safety monitoring: what to look for and when to look for it[J]. Epilepsia,2000,41 (Suppl 8) :S37-44.
7Guo CY, Ronen GM, Atkinson SA. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilegsy[ J]. Epilepsia,2001,42(9) : 1141-7.
8Kafali G, Erselcan T,Tanzer F. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years [ J ]. Clin Pediatr,1999.38(2) :93-8.
9Feldkamp J, Becker A, Witte OW, et al. Long-term anticonvulsant therapy leads to low bone mineral density-evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells[J]. Exp Clin Endocrinol Diabetes, 2000,108(1) :37-43.
10Telci A,Cakstay U,Kurt BB,et al.Changes in bone turnover and deoxypyridinoline levels in epileptic patients[J]. Clin Chem Lab Meal,2000,38(1) :47-50.
